Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension

Journal of Human Hypertension

Volumn 11, Issue SUPPL. 2, 1997, Pages

  Heuer, H J ^a   Schondorfer G ^a   Hogemann A M ^b  

^a LAB GmbH   (Germany)

^b Takeda Pharma GmbH   (Germany)

Author keywords

Ambulatory blood pressure monitoring; Candesartan cilexetil; Clinical study; Diurnal variation in blood pressure; Essential hypertension

Indexed keywords

CANDESARTAN HEXETIL;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0030720101     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Mallion J-M et al. Use of ambulatory blood pressure monitoring in the management of antihypertensive therapy. Drugs 1992; 44 (Suppl 1): 12-16.
2. Morimoto S, Ogihara T. TCV-116: a new angiotenin II type-1 receptor antagonist. Cardiovasc Drug Rev 1994; 2: 153-164.